
Sign up to save your podcasts
Or


NEW YORK (AP) — Walgreens Boots Alliance says it has agreed to be acquired by private equity firm Sycamore Partners as the struggling retailer looks to turn itself around after years of losing money.
Walgreens said Thursday that Sycamore will pay $11.45 per share, giving the deal an equity value just under $10 billion. Shareholders could eventually receive up to another $3 per share under certain conditions.
A buyout to take the drugstore chain private would give it more flexibility to make changes to improve its business without worrying about Wall Street’s reaction. The company has already been making some big changes as it seeks to turn around its business. Walgreens has been a public company since 1927.
Walgreens, founded in 1901, has been dealing with thin prescription reimbursement, rising costs, persistent theft and inflation-sensitive shoppers who are looking for bargains elsewhere. Walgreens is in the early stages of a plan to close 1,200 of its roughly 8,500 U.S. locations.
The Deerfield, Illinois, company had already shed about a thousand U.S. stores since it grew to nearly 9,500 after buying some Rite Aid locations in 2018.
The company also said last August that it was reviewing a U.S. health care operation it had expanded aggressively, and it might sell all or part of its VillageMD clinic business. That announcement came less than two years after the company said it would spend billions to expand it.
Shares of Walgreens shed nearly two thirds of their value last year. Walgreens said the transaction price represents a nearly 30% premium to the share price in December when reports of a deal first surfaced. Walgreens CEO Tim Wentworth confirmed in January that a sale process for the business was underway. Including debt, the value of the deal is just under $24 billion, the company said.
Walgreens said earlier this year it was making progress improving prescription reimbursement.
Walgreens has also taken steps to preserve cash. It said in January that it was suspending a quarterly dividend it has offered for more than 90 years, and it's been reducing its stake in the drug distributor Cencora this year to get cash in part to pay down debt.
Ultimately, the company has to improve its cash flow, whether it remains publicly traded or goes private, Leerink Partners analyst Michael Cherny said in a Feb. 23 research note.
“Management has not been shy about its push to improve the cash flow generation profile as part of the turnaround plan,” the analyst wrote. “Without cash flow, none of the value cases work.”
Walgreens Boots Alliance Inc. also runs nearly 3,700 international stores, with locations in the United Kingdom, Mexico, Thailand and Ireland.
The Walgreens buyout comes after competitor Rite Aid emerged last September as a private company from a Chapter 11 bankruptcy reorganization. Remaining publicly traded drugstore operators include the nation’s largest, CVS Health Corp., and retailers like Walmart and the grocer Kroger that run pharmacies at many of their locations.
They’re on. They’re off. They’re on again, but not for everyone. Or not immediately. Or maybe they are! Donald Trump’s tariffs, and his plans for more, are wreaking havoc on the economy before they are even a week old.
Consumer electronics retailer Best Buy saw its stock plunge as much as 13% this week after CEO Corie Barry told analysts on Tuesday that the stores will have to pass on to customers some of the cost of tariffs, raising prices and consequently reducing sales. New York Fed president John Williams said Tuesday he expects tariffs to increase inflation. Tariffs “filter into prices that consumers pay. That happens relatively soon,” he said.
Core inflation, which excludes volatile food and energy prices, has been falling steadily from a recent peak of 5.6% in 2022 to 2.6% in January, but still above the Fed’s ~2% target. Raising tariffs on Canada and Mexico by 25% and on China by 10% could add 0.5 to 0.8 percentage points to the core inflation rate, according to the Boston Fed.
Trump’s tariffs aren’t only affecting the U.S., said Bank of England governor Andrew Bailey. “The risks to the U.K. economy, and the world economy, are substantial,” Bailey told Parliament on Wednesday. He said there’s concern that Trump could lead the U.S. to withdraw from the International Monetary Fund and the World Bank, the two institutions launched after World War II to help avoid a repeat of the Great Depression. “That would be a very damaging thing for the world,” Bailey said.
Back home, EY chief economist Gregory Daco says steep tariff increases against top U.S. trading partners could create a “stagflationary shock — a negative economic hit combined with higher inflation — while triggering financial market volatility.”
Businesses are already upset over tariffs, which Ray Farris, chief economist at Prudential PLC told The Wall Street Journal will be “wildly disruptive to business investment plans.” Tariffs will inflate prices, creating “a shock to real household income just as household income growth is slowing because of slower employment and wage gains,” he said. Smelling the blowback from Canada and Mexico (Canada is boycotting U.S. goods, and Manitoba just banned U.S. alcohol from its liquor stores), Trump first announced that U.S. car makers will get an exemption for the next few weeks, then he delayed tariffs on Canada and Mexico for a month. Commerce Secretary Howard Lutnick said Wednesday that Trump is “thinking about a plan” to roll back some or all of the tariffs on trading partners. Whatever happens, U.S. trade partners are already spooked and angry and looking elsewhere for goods and markets, and tariffs are making the economy very unsteady.
“This thing could get off the rails pretty quickly,” said Tim Mahedy, chief economist at Access/Macro. “This is not at the level of the 1970s or 1980s. But it does have a whiff of stagflation, or a ministagcession.”
What do you think of Big Business This Week? Tell us how you really feel in this survey!
Elsewhere in TrumplandiaGet Big Business This Week in your inbox every week—and read it before everybody else! Sign up today.
The Usual SuspectsGen Z concert fans are paying an arm and a leg for tickets to see their favorite bands and singers, nearly three times as much in inflation-adjusted dollars as their parents paid in 1996 when the average ticket price for the top 100 tours was $25.81, about $52 when adjusted for inflation. By 2024, average ticket prices had risen to $135.92, The New York Times reports, citing data compiled by a music industry trade publication. By 2024, average ticket prices had risen to $135.92. Newly liberated concertgoers drove up prices after the Covid pandemic, but so did dynamic pricing systems, legalized scalping by ticket reselling apps, the consolidation of the live performance industry, and a sea change in the way artists make money: Where album sales used to make the fortunes of musicians into the early 2000s, now the penny—or less—per stream on music apps like Spotify, has prompted, if not forced, musicians to continue touring for decades to make money.
Elon’s WorldWhether or not you believe Elon Musk’s easily discredited accounts of billions in saving with his DOGE chainsaw, one thing is clear. Musk’s businesses are among the more significant recipients of U.S. government money. The Washington Post dove into Musk’s public business dealings, cataloguing some long fingers in the pocket of the U.S. Treasury and state governments. By their account, backed up by a trove of official documents, over the past two decades Musk’s businesses have received at least $38 billion in “government contracts, loans, subsidies and tax credits,” most of it in the past five years. Among the highlights:
From the publisher's feed

14,511 Listeners

1,213 Listeners

111,841 Listeners

56,409 Listeners

1,360 Listeners

1,867 Listeners

6,434 Listeners

2,118 Listeners

3,621 Listeners

6,447 Listeners

6,584 Listeners

574 Listeners

6,357 Listeners

1,527 Listeners

41,371 Listeners